Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN55488371
ISRCTN55488371
Completed
未知

An exploratory two-group randomised controlled trial of computerised cognitive remediation therapy (CRT) and treatment as usual versus treatment as usual alone in schizophrenia patients

South London and Maudsley NHS Trust (UK)0 sites120 target enrollmentApril 29, 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
South London and Maudsley NHS Trust (UK)
Enrollment
120
Status
Completed
Last Updated
7 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

  1. 2017 results in https://www.ncbi.nlm.nih.gov/pubmed/28866988 (added 24/01/2019)
Registry
who.int
Start Date
April 29, 2010
End Date
November 2, 2016
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
South London and Maudsley NHS Trust (UK)

Eligibility Criteria

Inclusion Criteria

  • •Participants will be entered into the study if they have:
  • •1\. A diagnosis of schizophrenia
  • •2\. Have been in touch with the mental health services for at least one year
  • •3\. Aged between 17 and 65 years old, either sex
  • •4\. Have a known cognitive deficit (poor performance in memory \[digit span] and/or cognitive flexibility \[WCST or Hayling Sentence Completion Test] in addition to poor social functioning \[score of 2 or more on Social Behaviour Schedule])

Exclusion Criteria

  • •1\. Plan to change their medication during the therapy phase of the study
  • •2\. Known substance dependence
  • •3\. Evidence of an organic cause to their cognitive difficulties (e.g. history of head injury)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
An intervention to reduce children?s exposure to secondhand smoke in the home
ISRCTN81701383niversity of Nottingham (UK)200
Completed
Not Applicable
Assessing the clinical- and cost-effectiveness of facet-joint injections in selected patients with non-specific low back paiow back painMusculoskeletal DiseasesLow back pain
ISRCTN12191542IHR Health Technology Assessment Programme - HTA (UK)150
Completed
Not Applicable
Studying the impact of Lorazepam on approach/avoidance behaviour in healthy individuals
ISRCTN12590498Psychiatric University Hospital (Psychiatrische Universitätsklinik) Zürich (PUK ZH)60
Completed
Phase 3
Speed of Increasing milk Feeds Trial
ISRCTN76463425niversity of Oxford (UK)2,804
Completed
Phase 3
A multicentre, phase III, randomised, double-blind, placebo-controlled trial of pravastatin added to first-line chemotherapy in patients with small cell lung cancer
ISRCTN56306957niversity College London (UK)860